Dermagraft engineered human dermal tissue with synthetic epidermal layer: Interim analysis shows a pivotal trial is meeting objectives, and the company said a P

Data for the trial's primary end point of complete wound closure, and secondary end points, such as rate of healing, were in line with expectations, ATIS said. Analysis was performed on half of the 20...